2228.HKPartnership•prnewswire•
XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration
Sentiment:Positive (85)
Summary
Strategic partnership leverages AI and robotics for novel therapeutics across oncology, immunology, inflammation, neurology, and metabolic diseases. CAMBRIDGE, Mass., Aug. 6, 2025 /PRNewswire/ -- XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 6, 2025 by prnewswire